New JAMA study: ~100 minutes of daily walking (no matter the speed) is linked to lower chronic low back pain risk and better longevity outcomes.

A summary of our 3-patient case series in Frontiers in Pain Research: low-dose ketamine plus PRT/somatic tracking, IFS/EMDR, breathwork & movement.

Fibromyalgia affects millions worldwide, causing widespread body pain, fatigue, sleep disturbances, cognitive issues, and mood changes. Despite its prevalence, treatment options remain limited.

Recent research finds promising results in using ketamine for short-term fibromyalgia relief, and case studies show potential for long-term relief for some patients with chronic pain, too.